dotarizine has been researched along with flunarizine in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (75.00) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albillos, A; Gandía, L; García, AG; Lara, B; López, MG; Villarroya, M | 1 |
Belcheva, S; Konstantinova, E; Petkov, VD; Petkov, VV; Vaglenova, J | 1 |
Bojanowski, K; Cervos-Navarro, J; Czernicki, Z; Jurkiewicz, J; Piechnik, S | 1 |
Gandía, L; García, AG; Lara, B; López, MG; Martínez-Sierra, R; Olivares, R; Torres, A | 1 |
García, AG; García-Palomero, E; Herrero, CJ; Lomax, RB; Montiel, C; Renart, J | 1 |
Abad-Santos, F; Cano-Abad, MF; García, AG; Moradiellos, J; Novalbos, J; Sánchez-García, P; Zapater, P | 1 |
Petkov, VD; Petkova, B | 1 |
Abad-Santos, F; Alonso, MT; Alvarez, J; García, AG; Montero, M; Novalbos, J; Zapater, P | 1 |
Belcheva, S; Konstantinova, E; Petkov, VD; Petkov, VV | 1 |
Belcheva, S; Kehayov, R; Konstantinova, E; Petkov, VD; Petkov, VV; Vaglenova, J | 1 |
Balfagón, G; Cano-Abad, M; García, AG; López, MG; Rosado, A; Ruiz-Nuño, A; Villarroya, M | 1 |
Abad-Santos, F; Arias, E; Cano-Abad, MF; Gallego-Sandín, S; García, AG; Novalbos, J; Rosado, A | 1 |
12 other study(ies) available for dotarizine and flunarizine
Article | Year |
---|---|
Dotarizine versus flunarizine as calcium antagonists in chromaffin cells.
Topics: Animals; Barium; Benzhydryl Compounds; Calcium; Calcium Channel Blockers; Calcium Radioisotopes; Catecholamines; Cattle; Cells, Cultured; Chromaffin System; Egtazic Acid; Flunarizine; Fura-2; Piperazines; Potassium | 1995 |
Behavioral effects of the Ca2+/5-HT antagonist dotarizine.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Calcium Channel Blockers; Drug Combinations; Exploratory Behavior; Flunarizine; Male; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists | 1994 |
Effects of the calcium channel blockers Dotarizine and Flunarizine on cerebrovascular reactivity.
Topics: Animals; Benzhydryl Compounds; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Cats; Cerebrovascular Circulation; Flunarizine; Hyperventilation; Male; Piperazines; Vasoconstriction | 1996 |
'Wide-spectrum Ca2+ channel antagonists': lipophilicity, inhibition, and recovery of secretion in chromaffin cells.
Topics: Animals; Benzhydryl Compounds; Calcium Channel Blockers; Catecholamines; Cattle; Chromaffin Cells; Flunarizine; Piperazines; Potassium; Secretory Rate | 1997 |
Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.
Topics: Animals; Arteries; Benzhydryl Compounds; Calcium Channel Blockers; Coronary Vessels; Female; Flunarizine; Male; Microinjections; Oocytes; Piperazines; Receptors, Serotonin; Serotonin Antagonists; Swine; Vasoconstriction; Vasodilator Agents; Xenopus laevis | 1997 |
Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+.
Topics: Animals; Benzhydryl Compounds; Calcium; Calcium Channel Blockers; Cattle; Cell Death; Cell Membrane; Cell Survival; Chromaffin Cells; Cytosol; Flunarizine; Lipid Bilayers; Piperazines; Potassium; Veratridine | 1999 |
Behavioral changes as a result of dotarizine or flunarizine influence on dopaminergic neurotransmission in the striatum.
Topics: Administration, Oral; Animals; Area Under Curve; Benzhydryl Compounds; Calcium Channel Blockers; Catalepsy; Corpus Striatum; Dopamine Antagonists; Flunarizine; Haloperidol; Injections, Intraperitoneal; Male; Piperazines; Rats; Rats, Wistar; Stereotypic Movement Disorder; Synaptic Transmission | 1998 |
Novel antimigraineur dotarizine releases Ca2+ from caffeine-sensitive Ca2+ stores of chromaffin cells.
Topics: Adrenal Medulla; Animals; Benzhydryl Compounds; Caffeine; Calcium; Cattle; Cells, Cultured; Chromaffin Cells; Flunarizine; Indoles; Migraine Disorders; Piperazines; Potassium; Thapsigargin; Vasodilator Agents | 1999 |
Does nitric oxide participate in the mechanism of action of dotarizine?
Topics: Animals; Arginine; Benzhydryl Compounds; Calcium Channel Blockers; Ergotamine; Flunarizine; Histamine; Male; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pain Threshold; Piperazines; Rats; Serotonin Receptor Agonists; Time Factors; Vasodilator Agents | 1998 |
Memory effects of the Ca2+ and 5-HT antagonists dotarizine and flunarizine.
Topics: Animals; Avoidance Learning; Benzhydryl Compounds; Calcium; Calcium Channel Blockers; Cinnarizine; Drug Interactions; Flunarizine; Male; Memory; Piperazines; Rats; Rats, Long-Evans; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists | 2000 |
Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility.
Topics: Animals; Benzhydryl Compounds; Blood Vessels; Calcium Channel Blockers; Cattle; Cerebrovascular Circulation; Electric Stimulation; Electrophysiology; Flunarizine; In Vitro Techniques; Male; Middle Cerebral Artery; Migraine Disorders; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Piperazines; Rabbits; Serotonin; Serotonin Antagonists; Vasodilator Agents | 2001 |
Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells.
Topics: Apoptosis; Benzhydryl Compounds; Calcium; Calcium Channel Blockers; Cell Line, Tumor; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Inhibitors; Flunarizine; Humans; Membrane Potentials; Mitochondria; Neuroblastoma; Piperazines; Serum Albumin, Bovine; Thapsigargin; Time Factors | 2005 |